Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions (Q48408756)

11 February 2018

title

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions (English)

1 reference

11 February 2018

0 references

1 reference

5

1 reference

11 February 2018

author name string

Jasmina B Mackic

1

1 reference

11 February 2018

James Bading

2

1 reference

11 February 2018

Jorge Ghiso

3

1 reference

11 February 2018

Larry Walker

4

1 reference

11 February 2018

Blas Frangione

6

1 reference

11 February 2018

Berislav V Zlokovic

7

1 reference

11 February 2018

publication date

1 June 2002

1 reference

11 February 2018

published in

Vascular Pharmacology

1 reference

11 February 2018

volume

38

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

303-313

1 reference

11 February 2018

Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Metabolic regulation of brain Abeta by neprilysin

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

beta-Amyloid precursor protein gene in squirrel monkeys with cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Permeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Differences between vascular and plaque core amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Aged Non-Human Primates: An Animal Model of Age-Associated Neurodegenerative Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Alzheimer's disease: genotypes, phenotypes, and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Survival rate and life span of rhesus monkeys at the Yerkes regional primate research center

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Characterization of beta-amyloid peptide from human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Animal models of cerebral beta-amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Amyloid in the brains of aged squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Biology of A beta amyloid in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

Clearance of amyloid beta-peptide from brain: transport or metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900198-2

7 January 2021

10.1016/S1537-1891(02)00198-2

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018